Background/Objectives: Idiopathic Carpal Tunnel Syndrome (CTS) can be an early manifestation of systemic amyloidosis, particularly transthyretin cardiac amyloidosis (ATTR-CA). The primary purpose of this retrospective case series was to describe the presence of amyloid deposits in tenosynovial tissue and explore potential cardiac involvement in patients undergoing carpal tunnel release surgery. Methods: From a cohort of 54 patients diagnosed with bilateral idiopathic CTS with surgical indication, 12 patients were selected for tenosynovial tissue samples, which were subsequently evaluated using Congo red staining and proteomic confirmation via mass spectrometry. Before the procedure, patients underwent a clinical assessment of medical history, electrocardiogram, and cardiac scintigraphy with Technetium-99 m 3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD). Transthoracic echocardiogram and cardiac magnetic resonance were subsequently performed in all patients with positive scintigraphy, while a subset of scintigraphy-negative patients underwent an echocardiogram. Results: Congo red staining identified amyloid deposits in 3 of the 12 patients (25%). Proteomic analysis confirmed ATTR amyloidosis deposits in 2 of these patients (17%). One of these 2 patients presented Perugini grade 3 uptake on cardiac scintigraphy, suspicious for ATTR-CA. Complete concordance across histology, proteomics, and cardiac imaging was observed in only 1 patient (8.3%). Three discordances were noted: one case of tenosynovial ATTR without evident cardiac disease, one patient with a discordant Congo red result likely reflecting low amyloid burden or tissue heterogeneity, and one with imaging findings suspicious for ATTR-CA despite a negative tenosynovial biopsy. Conclusions: Tenosynovial biopsy obtained during CTS surgery can reveal early amyloid deposition, which may precede overt cardiac involvement. The variability observed across findings underscores the need for a multimodal diagnostic approach that integrates histological, proteomic, and imaging data, thereby mitigating the risk of amyloidosis misclassification.
Vertebral augmentation techniques, including vertebroplasty and kyphoplasty, are widely used to relieve pain and restore spinal stability in patients with metastatic vertebral lesions. Despite their widespread use, the full spectrum and clinical significance of procedure-related complications remain incompletely characterised. This systematic review aims to summarise and characterise all reported complications associated with vertebral augmentation for metastatic thoracolumbar disease. A comprehensive search of PubMed/MEDLINE, Scopus, and Web of Science databases was performed. Studies reporting complications associated with vertebral augmentation procedures for metastatic thoracolumbar spinal fractures were included. Randomised controlled trials, observational studies, case series, and case reports were eligible. Due to substantial heterogeneity across studies, a descriptive synthesis was performed. A total of 76 studies were included, comprising 3234 patients and at least 5737 vertebral levels treated. The overall weighted complication rate was 25.5%, while the weighted rate of symptomatic complications was 3.41%. Cement leakage was the most frequently reported complication, with a weighted mean incidence of 20.7%, although the majority were asymptomatic. Other complications included postprocedural pain (1.77%), pulmonary cement embolism (1.08%), and adjacent level fractures (0.79%). Studies using CT imaging reported significantly higher cement leakage rates (28.6% vs 11.9%, p = 0.004). Case reports described rare but potentially severe complications, including needle-tract tumour seeding, tumour extrusion, and cement migration to cardiac structures. This review presents a comprehensive and detailed description of all complications of vertebral augmentation for treatment of metastatic spine disease and reinforce its safety. Differences in imaging protocols and reporting standards contribute to variability in reported complication rates. Further prospective studies with standardised complication reporting are needed.